NCT03335176

Brief Summary

The aim of this study is to assess the feasibility and the effects of a 6-week telerehabilitation on the three domains of the International Classification of Functioning, Disability and Health in HIV-infected patients under highly active antiretroviral therapy (HAART). HIV-infected patients were randomized either into an Endurance and Resistance Training Exercise (ERTE) group or a control (CON) group. Telerehabilitation was realized in a public fitness center, with online guidance and weekly telephone advice, 3 times per week for 6 weeks. Feasibility was determined by recruitment rate, retention rate and adverse events. Secondary outcomes were impact on body composition, inflammation and coagulation (C-reactive protein, D-dimer), physical fitness and quality of life (WHOQOL-HIV).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2017

Completed
Last Updated

November 7, 2017

Status Verified

October 1, 2017

Enrollment Period

5 months

First QC Date

October 31, 2017

Last Update Submit

November 2, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment rate

    Number of eligible participants who enrolled in the program out of the number were recruited

    At study completion (after 6 weeks)

  • Retention rate

    Percentage of patients lost to follow-up

    At study completion (after 6 weeks)

  • Adverse events

    Percentage of patients who experienced one or more adverse events

    At study completion (after 6 weeks)

Secondary Outcomes (12)

  • Weight

    Assessments at baseline and at 6 weeks

  • Lean body mass

    Assessments at baseline and at 6 weeks

  • Fat body mass

    Assessments at baseline and at 6 weeks

  • C-reactive protein

    Assessments at baseline and at 12 weeks

  • D-dimer

    Assessments at baseline and at 12 weeks

  • +7 more secondary outcomes

Study Arms (2)

Endurance and Resistance Training Exercise

EXPERIMENTAL
Behavioral: Endurance ad Resistance Training Exercise

Control group

NO INTERVENTION

Usual care

Interventions

Patients received a 6-week tele-supervised rehabilitation with 3 exercise sessions per week

Endurance and Resistance Training Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • under HAART treatment
  • native French speaker

You may not qualify if:

  • AIDS diagnosis
  • physical and/or psychiatric impairments that seriously impaired physical activity
  • pregnant
  • Unstable (defined by any modification of health outcomes during the last 6 months).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 31, 2017

First Posted

November 7, 2017

Study Start

November 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

November 7, 2017

Record last verified: 2017-10